INDICATION(S):

Gastroesophageal reflux disease associated with a history of erosive esophagitis

Pantoprazole for injection is indicated for short-term treatment (7 to 10 days) of adult patients with gastroesophageal reflux disease (GERD) and a history of erosive esophagitis.

Safety and efficacy of pantoprazole for injection as treatment of patients with GERD and a history or erosive esophagitis for more than 10 days have been demonstrated.

Pathological hypersecretion including Zollinger-Ellison Syndrome

Pantoprazole for injection is indicated for the treatment of pathological hypersecretory conditions including Zollinger-Ellison syndrome in adults.

For more details on safety, precautions and other pertinent information about this product, please click the link below to download the full product insert.

Formulation:     

Each 5 ml contains: Pantoprazole (as sodium) (as sulfate), pp 40 mg

Download Leaflet